(Q50969851)

26 March 2018

title

Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma. (English)

1 reference

26 March 2018

chronic obstructive pulmonary disease

main subject

1 reference

based on heuristic

inferred from title

beclomethasone dipropionate

1 reference

G Tatsis

1

1 reference

26 March 2018

K Kotsifas

2

1 reference

26 March 2018

V Filaditaki

3

1 reference

26 March 2018

G Makrantoni

4

1 reference

26 March 2018

S Boulia

5

1 reference

26 March 2018

publication date

1 May 2007

1 reference

26 March 2018

Journal of International Medical Research

published in

1 reference

26 March 2018

volume

35

1 reference

26 March 2018

issue

3

1 reference

26 March 2018

page(s)

361-373

1 reference

26 March 2018

Size analysis of a pressurized metered dose inhaler-delivered solution formulation by an Aerosizer-LD time-of-flight aerosol particle size spectrometer

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Mass output and particle size distribution of glucocorticosteroids emitted from different inhalation devices depending on various inspiratory parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 micrograms day-1 delivered as an extrafine aerosol in adults with moderate asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Pharmacokinetic and pharmacodynamic properties of inhaled beclometasone dipropionate delivered via hydrofluoroalkane-containing devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500311

10.1177/147323000703500311

21 January 2018

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018